3'-氨基-5'-甲基-苯乙酮 | 102877-45-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3'-氨基-5'-甲基-苯乙酮
• 中文别名: 苯酚4-异硫氰酸根合
• 英文名称: 1-(3-amino-5-methyl-phenyl)-ethanone
• 英文别名: 1-(3-Amino-5-methyl-phenyl)-aethanon；1-(3-Amino-5-methylphenyl)ethan-1-one；1-(3-amino-5-methylphenyl)ethanone
• CAS: 102877-45-2
• 化学式: C₉H₁₁NO
• mdl: MFCD18824026
• 分子量: 149.192
• InChiKey: KVDMLHRPIQOTCE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  3-甲基-5-硝基苯甲酰氯 在 乙醚 、 乙醇 、 镍 作用下， 生成 3'-氨基-5'-甲基-苯乙酮
  参考文献：
  名称：

  Butenandt et al., Chemische Berichte, 1959, vol. 92, p. 2172,2174

  摘要：

  DOI：

文献信息

• LUBRICANT COMPOSITION AND USE THEREOF
  申请人：Nakata Hiyoku

  公开号：US20120021253A1

  公开（公告）日：2012-01-26

  [Problem] Provided is a novel lubricant composition that is useful as a material of a lubricating layer of a magnetic recording medium. [Means for Resolution] The lubricant composition contains at least one kind of compound represented by the following Formula (1). In the formula, X represents a cyclic group that may be substituted, and Y represents a single bond or a linking group having a valency of 2 or more. Here, at least one of X and Y includes 1 or more polar groups such as a hydroxyl group; Z represents a linking group having a valency of 2 or more and constituted with a carbon atom (C), a fluorine atom (F), and 1 or 2 kinds of arbitrary atoms (here, a hydrogen atom is excluded); n represents a real number of 1 to 10; m represents a real number of 0 to 1; and s and t independently represent a real number of 1 or greater. XYZ—C n F 2n+1-m H m ] s ] t (1)

  [问题] 提供的是一种新型润滑剂组合物，可用作磁记录介质的润滑层材料。[解决方法] 该润滑剂组合物包含至少一种由以下式(1)表示的化合物。在该式中，X表示可能被取代的环状基团，Y表示具有2个或更多价的单键或连接基团。在此，X和Y中至少有一个包括1个或更多的极性基团，例如羟基；Z表示具有2个或更多价的连接基团，由碳原子(C)、氟原子(F)和1或2种任意原子(此处不包括氢原子)组成；n表示1到10的实数；m表示0到1的实数；s和t分别表示1或更大的实数。XYZ—CnF2n+1-mHm]s]t(1)
• Staurosporine Derivatives for Use in Alveolar Rhabdomyosarcoma
  申请人：Wachtel Marco

  公开号：US20080280880A1

  公开（公告）日：2008-11-13

  This invention relates to staurosporine derivatives are effective when used in combination with ionizing radiation for the delay of progression or treatment of a proliferative disease, especially a disease associated with a PAX/FKHR translocation including a PAX3/FKHR translocation and a PAX7/FKHR translocation, more especially a solid tumor disease such as a Sarcoma, most especially an Alveolar Rhabdomyosarcoma.
• STAUROSPORINE DERIVATIVES AS INHIBITORS OF FLT3 RECEPTOR TYROSINE KINASE ACTIVITY
  申请人：GRIFFIN James Douglas

  公开号：US20120252785A1

  公开（公告）日：2012-10-04

  The present invention relates to the use of staurosporines derivatives for the preparation of a drug for the treatment of diseases involving deregulated FLT3 receptor tyrosine kinase activity, especially for the curative and/or prophylactic treatment of leukemias and myelodysplastic syndromes, and to a method of treating diseases involving deregulated FLT3 receptor tyrosine kinase activity.
• US7973032B2
  申请人：——

  公开号：US7973032B2

  公开（公告）日：2011-07-05
• US8445479B2
  申请人：——

  公开号：US8445479B2

  公开（公告）日：2013-05-21